Global Vectra Helicorp Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:34 am

Competitors of Global Vectra Helicorp Ltd

All Competitor Stocks of Global Vectra Helicorp Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:25 am

Below is a detailed analysis of the quarterly data for Global Vectra Helicorp Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 129.35 Cr.. The value appears to be declining and may need further review. It has decreased from 134.94 Cr. (Mar 2025) to 129.35 Cr., marking a decrease of 5.59 Cr..
• For Expenses, as of Jun 2025, the value is 120.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 127.04 Cr. (Mar 2025) to 120.02 Cr., marking a decrease of 7.02 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.33 Cr.. The value appears strong and on an upward trend. It has increased from 7.90 Cr. (Mar 2025) to 9.33 Cr., marking an increase of 1.43 Cr..
• For OPM %, as of Jun 2025, the value is 7.21%. The value appears strong and on an upward trend. It has increased from 5.85% (Mar 2025) to 7.21%, marking an increase of 1.36%.
• For Other Income, as of Jun 2025, the value is 1.87 Cr.. The value appears to be declining and may need further review. It has decreased from 37.94 Cr. (Mar 2025) to 1.87 Cr., marking a decrease of 36.07 Cr..
• For Interest, as of Jun 2025, the value is 7.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.30 Cr. (Mar 2025) to 7.16 Cr., marking a decrease of 1.14 Cr..
• For Depreciation, as of Jun 2025, the value is 16.99 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17.00 Cr. (Mar 2025) to 16.99 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is -12.95 Cr.. The value appears to be declining and may need further review. It has decreased from 20.54 Cr. (Mar 2025) to -12.95 Cr., marking a decrease of 33.49 Cr..
• For Tax %, as of Jun 2025, the value is -27.18%. The value appears to be improving (decreasing) as expected. It has decreased from 38.56% (Mar 2025) to -27.18%, marking a decrease of 65.74%.
• For Net Profit, as of Jun 2025, the value is -9.43 Cr.. The value appears to be declining and may need further review. It has decreased from 12.63 Cr. (Mar 2025) to -9.43 Cr., marking a decrease of 22.06 Cr..
• For EPS in Rs, as of Jun 2025, the value is -6.74. The value appears to be declining and may need further review. It has decreased from 9.02 (Mar 2025) to -6.74, marking a decrease of 15.76.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:20 am

Growth

Last Updated: September 5, 2025, 4:50 am

Balance Sheet

Last Updated: October 10, 2025, 2:05 pm

Below is a detailed analysis of the balance sheet data for Global Vectra Helicorp Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 1.00 Cr..
• For Borrowings, as of Mar 2025, the value is 461.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 583.00 Cr. (Mar 2024) to 461.00 Cr., marking a decrease of 122.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 309.00 Cr.. The value appears to be improving (decreasing). It has decreased from 323.00 Cr. (Mar 2024) to 309.00 Cr., marking a decrease of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 791.00 Cr.. The value appears to be improving (decreasing). It has decreased from 928.00 Cr. (Mar 2024) to 791.00 Cr., marking a decrease of 137.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 483.00 Cr. (Mar 2024) to 442.00 Cr., marking a decrease of 41.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 349.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2024) to 349.00 Cr., marking a decrease of 96.00 Cr..
• For Total Assets, as of Mar 2025, the value is 791.00 Cr.. The value appears to be declining and may need further review. It has decreased from 928.00 Cr. (Mar 2024) to 791.00 Cr., marking a decrease of 137.00 Cr..

However, the Borrowings (461.00 Cr.) are higher than the Reserves (7.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Global Vectra Helicorp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.46. This value is below the healthy minimum of 5. It has decreased from 0.86 (Mar 24) to -0.46, marking a decrease of 1.32.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.46. This value is below the healthy minimum of 5. It has decreased from 0.86 (Mar 24) to -0.46, marking a decrease of 1.32.
• For Cash EPS (Rs.), as of Mar 25, the value is 49.37. This value is within the healthy range. It has decreased from 52.11 (Mar 24) to 49.37, marking a decrease of 2.74.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 15.19. It has decreased from 15.58 (Mar 24) to 15.19, marking a decrease of 0.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 15.19. It has decreased from 15.58 (Mar 24) to 15.19, marking a decrease of 0.39.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 387.28. It has increased from 359.09 (Mar 24) to 387.28, marking an increase of 28.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 75.74. This value is within the healthy range. It has decreased from 76.93 (Mar 24) to 75.74, marking a decrease of 1.19.
• For PBIT / Share (Rs.), as of Mar 25, the value is 25.90. This value is within the healthy range. It has increased from 25.68 (Mar 24) to 25.90, marking an increase of 0.22.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.67 (Mar 24) to 2.31, marking an increase of 0.64.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.46. This value is below the healthy minimum of 2. It has decreased from 0.86 (Mar 24) to -0.46, marking a decrease of 1.32.
• For PBDIT Margin (%), as of Mar 25, the value is 19.55. This value is within the healthy range. It has decreased from 21.42 (Mar 24) to 19.55, marking a decrease of 1.87.
• For PBIT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 7.15 (Mar 24) to 6.68, marking a decrease of 0.47.
• For PBT Margin (%), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 10. It has increased from 0.46 (Mar 24) to 0.59, marking an increase of 0.13.
• For Net Profit Margin (%), as of Mar 25, the value is -0.11. This value is below the healthy minimum of 5. It has decreased from 0.23 (Mar 24) to -0.11, marking a decrease of 0.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is -3.05. This value is below the healthy minimum of 15. It has decreased from 5.53 (Mar 24) to -3.05, marking a decrease of 8.58.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.71. This value is within the healthy range. It has increased from 8.48 (Mar 24) to 10.71, marking an increase of 2.23.
• For Return On Assets (%), as of Mar 25, the value is -0.08. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to -0.08, marking a decrease of 0.20.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.90. This value is within the healthy range. It has decreased from 1.08 (Mar 24) to 0.90, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 1. It has increased from 1.91 (Mar 24) to 4.79, marking an increase of 2.88.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has increased from 0.59 (Mar 24) to 0.63, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1.5. It has decreased from 0.51 (Mar 24) to 0.50, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.45 (Mar 24) to 0.43, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.55. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 17.55, marking an increase of 17.55.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.21. This value is within the healthy range. It has increased from 3.20 (Mar 24) to 3.21, marking an increase of 0.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 3. It has decreased from 1.04 (Mar 24) to 0.98, marking a decrease of 0.06.
• For Enterprise Value (Cr.), as of Mar 25, the value is 426.31. It has increased from 196.31 (Mar 24) to 426.31, marking an increase of 230.00.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 24) to 0.78, marking an increase of 0.39.
• For EV / EBITDA (X), as of Mar 25, the value is 4.02. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 4.02, marking an increase of 2.20.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.61, marking an increase of 0.27.
• For Price / BV (X), as of Mar 25, the value is 15.80. This value exceeds the healthy maximum of 3. It has increased from 7.90 (Mar 24) to 15.80, marking an increase of 7.90.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.61, marking an increase of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness